The store will not work correctly when cookies are disabled.
4-ethoxy-N-(5-iodopyridin-2-yl)-3-nitrobenzamide
ID: ALA4085230
PubChem CID: 2980643
Max Phase: Preclinical
Molecular Formula: C14H12IN3O4
Molecular Weight: 413.17
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCOc1ccc(C(=O)Nc2ccc(I)cn2)cc1[N+](=O)[O-]
Standard InChI: InChI=1S/C14H12IN3O4/c1-2-22-12-5-3-9(7-11(12)18(20)21)14(19)17-13-6-4-10(15)8-16-13/h3-8H,2H2,1H3,(H,16,17,19)
Standard InChI Key: IXGQUZFUNXKLBX-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
3.8410 -2.1544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8399 -2.9739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5479 -3.3829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2576 -2.9734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2548 -2.1508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5461 -1.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9659 -3.3809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9672 -4.1981 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6730 -2.9712 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3814 -3.3787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3780 -4.1943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0855 -4.6017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7936 -4.1920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7897 -3.3706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0816 -2.9669 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1319 -3.3819 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4245 -2.9728 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1312 -4.1991 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.5025 -4.5985 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0
3.1332 -1.7459 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4256 -2.1547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7178 -1.7463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 2 0
7 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
2 16 1 0
16 17 1 0
16 18 2 0
13 19 1 0
1 20 1 0
20 21 1 0
21 22 1 0
M CHG 2 16 1 17 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 413.17 | Molecular Weight (Monoisotopic): 412.9873 | AlogP: 3.25 | #Rotatable Bonds: 5 |
Polar Surface Area: 94.36 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.98 | CX Basic pKa: 1.00 | CX LogP: 3.51 | CX LogD: 3.51 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.46 | Np Likeness Score: -2.26 |
References
1. Siddiqui-Jain A, Hoj JP, Hargiss JB, Hoj TH, Payne CJ, Ritchie CA, Herron SR, Quinn C, Schuler JT, Hansen MDH.. (2017) Pyridine-pyrimidine amides that prevent HGF-induced epithelial scattering by two distinct mechanisms., 27 (17): [PMID:28780159] [10.1016/j.bmcl.2017.07.063] |